Endothelins (ET-1, -2, -3) display pleiotropic activities, by signalling through G-protein-coupled membrane receptors. We show here that ET-1 and ET-3 stimulate within minutes the tyrosine phosphorylation of a 42 kDa protein (p42) in primary cultures of mouse embryo astrocytes, but not in any of two subclones of rat astrocytoma C6 cells. This effect, measured by anti-phosphotyrosine immunoblotting of cell extracts, was also observed in response to bradykinin, platelet-derived growth factor, the phorbol ester phorbol 12-myristate 13-acetate and the G-protein activator fluoroaluminate. Pretreatment of cells with pertussis toxin, which inactivates G,/GO proteins, did not affect these responses. However, down-regulation of protein kinase C completely blocked the response to phorbol ester and fluoroaluminate and at least partially impaired the ET-lstimulated phosphorylation of p42. We have identified p42 as
INTRODUCTION
Tyrosine phosphorylation of cellular proteins is undoubtedly recognized as a critical process leading to proliferation and transformation. A large number of membrane receptors as well as cytosolic proto-oncogene products have been identified as tyrosine kinases mediating the biological activity of polypeptide growth factors, such as insulin, epidermal growth factor and platelet-derived growth factor (PDGF) Cantley et al., 1991) . Tyrosine phosphorylation may also be involved in the regulation of cellular processes distinct from growth control, since non-proliferating cells, like blood platelets or neurons, have been shown to contain high tyrosine kinase activities (Tuy et al., 1983; Brugge et al., 1985) .
The actions of other external stimuli, such as hormones and neurotransmitters, are mediated by receptors with seven transmembrane domains and by heterotrimeric G-proteins (Bouvier, 1990; Strosberg, 1991) . One of the associated intracellular signalling pathways includes stimulation of phospholipase C (PLC), with subsequent increases of diacylglycerol, cytosolic inositol trisphosphate and Ca2 , followed by the activation of protein kinase C (PKC).
Although these two major signal-transduction pathways, the tyrosine kinase and the PKC pathways, first appeared to be independently controlled, it soon became evident that some cross-talk does exist: at least one of the phospholipase isoenzymes, PLC-y1, is activated after phosphorylation by receptor tyrosine kinases (Margolis et al., 1990; Nishibe et al., 1990) , whose activity is in turn inhibited by PKC-induced phosphorylation (Countaway et al., 1990) . In addition, early p42maPk, a mitogen-activated protein (MAP) kinase, on the basis of the following data: by sequential immunoblotting with antiphosphotyrosine and anti-MAP kinase antibodies, (i) similar kinetics are observed for p42 phosphorylation and the decrease in p42maPk electrophoretic mobility, likely corresponding to its tyrosine/threonine phosphorylation [de Vries-Smits, Boudewijn, Burgering, Leevers, Marshall and Bos (1992) Nature (London) 357, 602-604]; (ii) p42 and the shifted form of p42rmaPk co-migrate on SDS/PAGE; (iii) the myelin-basic-protein kinase activity of p42 mPk is stimulated by ET-1, in parallel with the tyrosine phosphorylation of p42. In conclusion, these findings strongly suggest that endothelins can stimulate the tyrosine phosphorylation and activation of p42ma^pk in astrocytes, via pertussis-toxin-insensitive G protein and protein kinase Cdependent and -independent pathways. reports on thrombin (Ferrel and Martin, 1988; Golden and Brugge, 1989) , as well as much more recent data on bombesin, vasopressin, bradykinin and endothelin (ET) (Force et al., 1991; Leeb-Lundberg and Song, 1991; Zachary et al., 1991a,b) (Cooper et al., 1982; Nakamura et al., 1983; Cooper and Hunter, 1985; Rossomando et al., 1989; Tobe et al., 1991) . More recently, tyrosine phosphorylation of the same proteins was shown to be stimulated by fluoroaluminate (AlF4-) (Anderson et al., 1991) , a direct activator of G-proteins, and by thrombin (Kohno and Pouyssegur, 1986; L'Allemain et al., 1991) . These proteins constitute a rapidly growing family of serine/threonine protein kinases that are activated by a variety of signals via both tyrosine and threonine phosphorylation Pelech and Sanghera, 1992a,b) : they are known as mitogen-activated protein (MAP) kinases or extracellular signal-regulated kinases (ERKs). A number of important regulatory proteins, including p9Orsk (S6 kinase) and the proto-oncogene products raf, myc and jun, have been found to be phosphorylated by the MAP kinases p42rmaPk (or ERK2) and p44mapk (or ERK 1), demonstrating the role that these proteins may play in the control of various cellular functions. In order to understand better the regulation of these activities in brain, where the highest levels of MAP kinase expression were observed McCumber et al., 1990; Ladenheim et al., 1993) , and suggest a role of the kinase cascade in the transduction of ET signals.
(Amersham). Western blotting was performed using 2.5 fig/ml monoclonal anti-phosphotyrosine antibody as first antibody and peroxidase-conjugated rabbit anti-mouse immunoglobulins as second antibodies. ECL reagents (Amersham) were used for detection of peroxidase activity. For analysis of MAP kinase expression in cell extracts, antibodies were washed out from filters used for analysis of tyrosine phosphorylation by 10 min treatment in 0.1 M glycine (pH 2.5). Filters were then re-incubated with rabbit antibodies directed against a highly conserved MAP kinase peptide (Adams and Parker, 1991) , and then with peroxidase-conjugated donkey anti-rabbit immunoglobulins. Detection reagents were used as described above.
MATERIALS AND METHODS Materials
Endothelins (ET-1 and ET-3) were synthesized as described by Couraud et al. (1991) 
Cell cultures
Rat astrocytoma C6 cells were grown as reported by . Primary cultures of astrocytes were prepared as previously described McCumber et al., 1990; Ladenheim et al., 1993) . Briefly, cells were obtained from brains of 16-day Swiss-mouse embryos and plated on poly-L-ornithine (1.5 /Lg/ml)-precoated dishes of 60 mm diameter, in a medium composed of a 1:1 (v/v) mixture of minimal essential medium and F12 nutrient (Seromed, Berlin, Germany), supplemented with 10% Nu-serum (Collaborative Research, Lexington, MA, U.S.A.), 33 mM glucose and 5 mM Hepes, pH 7.4. Treatments were performed on 18-20-day cultures; at this time cells were immunocytochemically defined as confluent monolayers of pure glial cells (El-Etr et al., 1989) . Cells were washed and maintained in serum-free medium for 16-18 h before incubation with effectors. Where indicated, the cells were pretreated for 18 h with 160 nM PMA or 0.1 fIg/ml PTX in serum-free medium; the cells were then washed three times before addition of the effectors. A1F4-was prepared fresh daily by mixing 1O vol. of NaF (300 mM) with 1 vol. of AlCl3 (1 mM). This solution was added to the cell medium to give final concentrations of 30 mM NaF and 10 ,uM AlCl3.
Immunoblottlng
Quiescent cells (2.5 x 106) were incubated for various times (1-60 min) at 37°C in the presence of effectors. The reaction was stopped by aspiration of the medium and immediate addition to the cells of 250 /ul of SDS-lysis buffer (Laemmli, 1970) p42 labelling was completely abolished by competition with an excess (4 mM) of phosphotyrosine, but not by similar amounts of phosphothreonine or phosphoserine (results not shown).
Time course of p42 tyrosine phosphorylafton
The time course of increase in p42 tyrosine phosphorylation in astrocytes was monitored by the same immunoblotting procedure, using cells treated with 10 nM ET-l or ET-3 for 1 to 60 min. As shown in Figure 2( Figure 2 (a) was thoroughly washed to remove bound antibodies, then reincubated with antibodies directed against a MAP kinase peptide conserved in p42m&Pk and p44mapk (Adams and Parker, 1991) . As shown in Figure 2 (b), these antibodies identified a major 42 kDa and a minor 44 kDa protein, corresponding to p42maPk and p44rmapk respectively Pelech and Sanghera, 1992a,b) . A slight shift in electrophoretic mobility of both proteins, to higher apparent molecular masses, was observed after stimulation by ET-1 for 10-60 min or by ET-3 for 1-60 min (see also Figure 6b ). This observation is consistent with previous data indicating a decrease in the electrophoretic mobility of p42mPk in parallel to its activation by threonine and tyrosine phosphorylation (de Vries-Smits et al., 1992 (Figure 2a ; see also Various neurotransmitters and growth factors were compared with ET-1 and ET-3 for their efficiency in promoting p42 tyrosine phosphorylation in astrocytes. Like ET-1 and ET-3, PDGF and bradykinin evoked p42 phosphorylation (Figure 3a) , whereas insulin, angiotensin II, carbachol or isoprenaline had no effect. Because actions of ETs, bradykinin and PDGF all lead to mobilization of intracellular Ca2+ and activation of PKC, we tried to assess the contribution of this intracellular pathway to p42 phosphorylation. Whereas direct activation of PKC by a saturating concentration of PMA (160 nM) increased p42 phosphorylation, no effect was observed when the intracellular Ca2l concentration was raised by addition of the ionophore A23187; neither was any potentiation of the PMA effect by A23187 (Figure 3a) . As shown in Figure 3( Cell lysates from astrocytes stimulated for 10 min by ET-1 (10 nM), ET-3 (10 nM), insulin (5 #g/ml), PDGF (25 ng/ml), isoprenaline (10 uM), carbachol (1 mM), angiotensin 11 (100 nM), bradykinin (100 nM) or PMA (160 nM) were electrophoresed in MBP-containing SDS/polyacrylamide gel. SDS was removed from the gel by washing, and, after protein denaturation and renaturation, MBP kinase activity was assayed in the gel in the presence of [y-32P]ATP as described in the Materials and methods section. After extensive washings, the gel was dried and submifted to autoradiography.
added in conjunction with ET-1, p42 phosphorylation appeared further enhanced (lane 4). In PKC-depleted astrocytes (lanes 5-8), the AlF4-response was largely decreased (lane 7), suggesting that the PKC-dependent pathway of p42 phosphorylation is essentially mediated by G-proteins. Neither ET-1 or AlF4--induced p42 phosphorylation was affected by pretreatment of cells with PTX (lanes 9-12), in conditions where adenylate cyclase inhibition and PLC stimulation by ET-1 were totally and partially blocked, respectively . These data indicate that PTX-insensitive G-protein(s) are involved in p42 phosphorylation. To establish definitively the identity of p42 with p42 nPk, MBP kinase activity was measured in a gel containing MBP, a known substrate of MAP kinase. The kinase assays were performed as described in the Materials and methods section, by incubating the MBP-containing gel with [y-32P]ATP after renaturation of the proteins. As shown in Figure 5 , MBP was phosphorylated in control astrocytes by two proteins with apparent molecular masses of 55 and 42 kDa. Stimulation by either ET-1 or ET-3 significantly increased the MBP kinase activity of the 42 kDa protein (p42maPk), whereas the activity of the 55 kDa protein remained largely unchanged. This 55 kDa protein might correspond to the recently described p54 MAP kinase isoform, distantly related to p42maPk and p44mapk (Pelech and Sanghera, 1992a (Pelech and Sanghera, 1992a Recent progress has been made towards the understanding of upstream regulation of MAP kinases and the role of PKC in this regulation Pelech and Sanghera, 1992a,b) . Although p42mk and p44maP, which are maximally activated via both tyrosine and threonine phosphorylation, undergo limited autophosphorylation on tyrosine residues, they appear to require an activating factor (MAP kinase kinase) which has been identified itself as a threonine/tyrosine protein kinase (Rossomando et al., 1992; Nakielny et al., 1992) and shown to be induced by PMA treatment (Adams and Parker, 1992) . Further upstream in this kinase cascade, a role for the proto-oncogene products p74ra" and p21Jr" has been postulated, which would at least partly mediate the stimulation of MAP kinases by PKC (for review see Pelech and Sanghera, 1992b (Durieu-Trautman et al., 1991 and neurons (Giaid et al., 1989) , might participate in the modulation of the glial proliferation and/or neurotrophic activity during brain development or tissue repair.
